Other Targets

These compounds act on targets other than 7-TM receptors, nuclear receptors, enzymes, ion channels, protein interactions, transporters and do not have DNA crosslinking activity. Other targets include imidazoline receptors and sigma receptors. This list of compounds also includes products with known applications, but with unknown or non-specific mode of action.

产品编码 CAS号 产品名称 描述
FA55835 183552-38-7
785804-17-3

Abarelix acetate

FA158666 59-53-0

N-Acetyl-DL-penicillamine

Protective agent against mercuric chloride poisoning
BA178432 920289-29-8

AGG-523

BA173042 1415036-82-6

AGN 220653

FA177523 33458-93-4

AH 6809

BA177429 126048-33-7

AL 3152 NEW

FA01736 90058-29-0

Alaptide

Nootropic agent; affects dopaminergic system
FA17279 26750-81-2

Alibendol

Anti-spasmodic, choleretic and cholekinetic agent
FA17334 645-05-6

Altretamine

Alkylating agent; cytotoxic; antineoplastic
FA17353 20537-88-6

Amifostine

Radio- and chemoprotective agent
W-105849 521-17-5

5-Androstenediol

BA177430 541550-19-0

Apilimod NEW

BA177431 870087-36-8

Apilimod mesylate NEW

BA176962 5291-32-7

APR 246

BA177440 1232221-74-7

APY0201 NEW

BA177432 32571-49-6

AQ-13 (2HCl) NEW

FA73663 113-80-4

[Arg8]-Vasotocin trifluoroacetate

FA17994 88495-63-0

Artesunate

Prodrug of dihydroartemisin (DHA); antimalarial
FA172879 1176760-49-8

AZD 4877

BA177711 2091134-68-6

AZD4205

BA178067 64748-79-4

Azumolene

FB18131 80573-04-2

Balsalazide

Prodrug of 5-aminosalicylic acid; anti-inflammatory BIO-X
BB178048 1632118-69-4

BAR-501

BB178033 1632118-70-7

BAR 501 impurity

BB177693 1443763-60-7

BAY1161909

FB18146 138356-09-9

BD 1008 dihydrobromide

Sigma (σ) receptor antagonist BIO-X
FB18147 150208-28-9

BD 1063

Antagonist of σ1 receptor BIO-X
FB18148 191744-13-5

BDP 37

BIO-X
FB171048 86541-75-5

Benazepril

FB18170 19428-14-9

Benproperine phosphate

Anti-tussive agent
FM162104 1622988-14-0

cis-Benvitimod

Aryl hydrocarbon receptor (AhR) agonist
FD167852 79338-84-4

Benvitimod

Aryl hydrocarbon receptor (AhR) agonist
FB18200 68-90-6

Benziodarone

Uricosuric agent
IC58278 90357-06-5

Bicalutamide

Androgen receptor antagonist
FB18605 576-19-2

Biocytin

BB178052 287980-85-2

BIRG 613 BS

BB178056 287980-84-1

BIRG 616 BS

NB178209 214139-48-7

(2R,3R,5R)-2,5-Bis(benzyloxy)-3-hydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide

BB178452 953769-46-5

BLZ 945

FB168813 1407495-02-6

Bococizumab

FB170950 1607799-13-2

Bremelanotide acetate

BB162705 76455-48-6

4-Bromo-A23187

Non-fluorescent Ca2+ ionophore; for calibrating fluorescent Ca2+ probes
FA103795 262442-90-0

BSF-466895

FB19345 65002-17-7

Bucillamine

Potential treatment for gout and rheumatoid arthritis
BB178194 1026315-97-8

2-Butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine

FC171039 77107-46-1

Calmodulin

BC178189 1135251-65-8

(2S)-N-[(4-Carbamimidoylphenyl)methyl]-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide

BC162800 577696-37-8

Cardionogen 1

Promotes cardiomyocyte generation
BC177445 1542705-92-9

CB 5083 NEW

FC175578 443798-55-8

Cdk1/2 Inhibitor III

  Page 1 of 6 Next Page
Please Wait...